Beginning in fall 2022, pediatric, adolescent and young adult patients with cancer and blood disorders in the greater Pacific Northwest will be cared for at a new state-of-the-art facility specifically designed for transformative, patient-centered care.
Read full post »
Starting today, Seattle Children’s is offering appointments to children between the ages of 6 months and 5 years (under 6 years old) to receive the Pfizer-BioNTech and Moderna COVID-19 vaccines, based on recent approvals from the CDC, Washington State Department of Health and the Western States Scientific Safety Review Workgroup. We are grateful to be able to offer COVID-19 vaccines to young patients.
Read full post »
We are pleased to announce the launch of a new intensive outpatient program (IOP) at Seattle Children’s for patients with eating disorders. The Eating Disorders IOP is designed for children and youth with high-acuity eating disorders who don’t require inpatient care but need more than typical outpatient care can provide.
Read full post »
Seattle Children’s Therapeutics has opened a new study that will evaluate the safety and feasibility of CAR T-cell immunotherapy in patients with bone cancer. The ENLIGHTen-01 study is approved for patients ages 15 to 30 years old who have refractory or progressive osteosarcoma. It is Seattle Children’s first study of CAR T-cell therapy for this patient population.
Read full post »
Provider Grand Rounds
Year-round on Thursdays from 8 to 9 a.m. Learn more.
Read full post »
From: Dr. Jay Santos, Urgent Care Medical Director and Dr. Tony Woodward, ED Medical Director
- We continue to experience extreme high volumes in the ED and our urgent care clinics (UCs).
- Please use the Emergency or Urgent Care Referral Guide when referring patients.
- When referring a patient to the ED, please call the ED Communications Center at 206-987-8899 to alert us they are coming.
Read full post »
We’re excited to announce a June 1, 2022 opening for the first finished spaces of Seattle Children’s much-anticipated new addition — formerly called Building Care during construction and now referred to as Forest B (our buildings’ zones are Forest, Mountain, River and Ocean). The finished spaces include a parking garage for patients and families and a new main lobby that will serve as our 24/7 main entrance. The current main entrance will still be open to patients and families daily until 10 p.m.
Read full post »
From: Dr. Jeff Sperring, CEO, and Dr. Mignon Loh, division chief, Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapies and director, Ben Towne Center for Childhood Cancer Research
We are thrilled to share that the recently announced restructure of our region’s cancer partnership and the transfer of SCCA’s outpatient Pediatric Blood and Marrow Transplant Program to Seattle Children’s will bring all pediatric cancer and blood disorder programs under one roof at Seattle Children’s.
Read full post »
From: Dr. Elaine Albert, Medical Director, Inpatient Access and Dinarte Viveiros, Vice President of Patient Care Services and Associate Chief Nurse, Inpatient and Emergency Services
Measles Mimics
- We have had a number of patients present to our Emergency Department (ED) and Urgent Care (UC) with possible measles. While we are not seeing an increase in measles cases, an unidentified patient or family member concerning for measles can have a huge impact on our facilities. These have caused the closures of our urgent care clinics and ED waiting rooms at times. Confirmed measles cases have resulted in exposures and the need for immunizations or immunoglobulin for patients who are unvaccinated or severely immunocompromised.
- If you suspect measles and are sending a patient for evaluation, please call first at 206-987-8899 so we can provide a safe way to enter a room and be evaluated without impacting other patients. Please also advise the family to wait in their car and call us on arrival.
Read full post »